Polypills with or without aspirin for primary prevention of cardiovascular disease

Polypills with or without aspirin for primary prevention of cardiovascular disease

Detaylı Bibliyografya
Asıl Yazarlar:	Mant, J, McManus, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2021

Benzer Materyaller

Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study
Yazar:: Virdee, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
Yazar:: Jowett, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Polypill for cardiovascular disease prevention.
Yazar:: Dalton, A
Baskı/Yayın Bilgisi: (2013)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.
Yazar:: Sue Jowett, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

The Concept of the Polypill in the Prevention of Cardiovascular Disease
Yazar:: Brandon Wiley, ve diğerleri
Baskı/Yayın Bilgisi: (2014-04-01)

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
Yazar:: J. Masjuan, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
Yazar:: Omneya A. Kandil, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
Yazar:: Apichard Sukonthasarn, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.
Yazar:: Sheppard, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
Yazar:: Lopez-Lopez JP, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
Yazar:: Gunaratne Padma S, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Medicinal herbs: Potential polypills in cardiovascular diseases
Yazar:: Samaneh Noroozi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Exercise Rehabilitation in Heart Disease: the real “polypill” for primary and secondary prevention
Yazar:: Massimo F. Piepoli
Baskı/Yayın Bilgisi: (2005-06-01)

The polypill: the solution for prevention of coronary heart disease?
Yazar:: Hendarto Natadidjaja
Baskı/Yayın Bilgisi: (2016-02-01)

Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.
Yazar:: Sheppard, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

THE ROLE OF POLYTABLETS (POLYPILL) IN THE TREATMENT OF CHRONIC CARDIOVASCULAR DISEASES
Yazar:: Николай Владимирович Абрамов, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Role of aspirin in primary prevention of cardiovascular disease
Yazar:: Patrono, C, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
Yazar:: VanWormer JJ, ve diğerleri
Baskı/Yayın Bilgisi: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
Yazar:: Ying Xing, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study
Yazar:: Ramin Ravangard, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
Yazar:: Lilian Grigorian-Shamagian, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Maybe it's time for something a little different? The extent to which current pharmacotherapy practice conforms to national guidelines for primary for cardiovascular disease prevention
Yazar:: Sheppard, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The use of polypills in cardiovascular disease management: Benefits vs challenges
Yazar:: Yamaan Adil, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review.
Yazar:: Reza Jahangiri, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
Yazar:: Hennekens, C, ve diğerleri
Baskı/Yayın Bilgisi: (1989)

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
Yazar:: Gautam Satheesh, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
Yazar:: Yinong Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Redefining the polypill: pros and cons in cardiovascular precision medicine
Yazar:: Siddharth Birla, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
Yazar:: Lozano R, ve diğerleri
Baskı/Yayın Bilgisi: (2015-07-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
Yazar:: Sergio Coccheri
Baskı/Yayın Bilgisi: (2017-04-01)

Aspirin for prevention of cancer and cardiovascular disease.
Yazar:: Rose, P, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
Yazar:: Gautam Satheesh, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
Yazar:: Eleni Giannopoulou, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
Yazar:: Athena L. Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
Yazar:: Athena L. Huang, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Preventing the progression of climate change: one drug or polypill?
Yazar:: Hugh Montgomery
Baskı/Yayın Bilgisi: (2017-03-01)

Maybe it's time for something a little different? The extent to which current pharmacotherapy practice conforms to national guidelines for stroke and cardiovascular disease prevention
Yazar:: Sheppard, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Yazar:: Price, H, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Polypill holds promise for people with chronic disease
Yazar:: Jacqui Wise
Baskı/Yayın Bilgisi: (2005-12-01)

Aspirin in the primary prevention of vascular disease Reply
Yazar:: Baigent, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)